| Title |
Topical treatments for chronic plaque psoriasis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2013
|
| DOI | 10.1002/14651858.cd005028.pub3 |
| Pubmed ID | |
| Authors |
Anne R Mason, James Mason, Michael Cork, Gordon Dooley, Helen Hancock |
| Abstract |
Chronic plaque psoriasis is the most common type of psoriasis, and it is characterised by redness, thickness, and scaling. First-line management of chronic plaque psoriasis is with topical treatments, including vitamin D analogues, topical corticosteroids, tar-based preparations, dithranol, salicylic acid, and topical retinoids. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Denmark | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 386 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | <1% |
| Ireland | 1 | <1% |
| South Africa | 1 | <1% |
| Qatar | 1 | <1% |
| Japan | 1 | <1% |
| Unknown | 381 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 61 | 16% |
| Student > Bachelor | 48 | 12% |
| Researcher | 46 | 12% |
| Student > Ph. D. Student | 30 | 8% |
| Student > Postgraduate | 23 | 6% |
| Other | 66 | 17% |
| Unknown | 112 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 153 | 40% |
| Pharmacology, Toxicology and Pharmaceutical Science | 21 | 5% |
| Nursing and Health Professions | 19 | 5% |
| Psychology | 14 | 4% |
| Agricultural and Biological Sciences | 13 | 3% |
| Other | 46 | 12% |
| Unknown | 120 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 May 2022.
All research outputs
#1,073,429
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#2,162
of 11,499 outputs
Outputs of similar age
#7,773
of 210,450 outputs
Outputs of similar age from Cochrane database of systematic reviews
#31
of 205 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,450 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 205 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.